by Virtus | Oct 18, 2026 | Respiratory Preclinical Research
Choosing the right respiratory CRO (Contract Research Organisation) can be an important decision for pharmaceutical and biotechnology companies developing new treatments for respiratory disease. Preclinical respiratory research involves more than selecting an...
by Virtus | Sep 5, 2026 | Respiratory Preclinical Research
Respiratory toxicology studies are an important component of preclinical drug development, particularly when a therapeutic is intended to treat diseases of the lungs and airways or is administered directly to the respiratory tract. Before a new respiratory therapeutic...
by Virtus | Sep 5, 2026 | Respiratory Preclinical Research
IND-enabling respiratory studies are an important part of the preclinical drug development process for new respiratory therapeutics. Before a potential treatment can progress into human clinical trials, pharmaceutical and biotechnology companies need appropriate...
by Virtus | Sep 4, 2026 | Respiratory Preclinical Research
Respiratory pharmacology is an important field of pharmaceutical research focused on understanding how medicines interact with the respiratory system and how therapeutic compounds can be developed to treat diseases affecting the lungs and airways. From asthma and...
by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Acute lung injury models play a fundamental role in respiratory drug development by allowing researchers to investigate the biological mechanisms that drive severe pulmonary inflammation and tissue damage. These models are widely used throughout preclinical...
by Virtus | Aug 5, 2026 | Respiratory Preclinical Research
Pulmonary fibrosis preclinical models play a critical role in respiratory drug development by helping researchers understand the mechanisms that drive progressive lung scarring and evaluate new therapeutic approaches before clinical trials begin. Pulmonary fibrosis is...